Clinical research faces immense pressure to optimize trial efficiency, reduce failure rates, and deliver effective therapies to patients faster. PGxAI empowers Contract Research Organizations (CROs) and biopharmaceutical sponsors with advanced pharmacogenomic (PGx) insights, leveraging machine learning and real-world data to streamline trial design. By identifying optimal patient cohorts and predicting drug-gene interactions upfront, CROs can enhance trial success, mitigate costly late-stage failures, and strengthen sponsor relationships.
• Targeted Patient Stratification Identify the right participants based on genetic and molecular markers.
• Reduced Adverse Events Minimize adverse drug reactions through genetically informed dosing.
• Optimized Protocols Refine enrollment criteria and dosing strategies in real time, improving trial success rates.
• Scalable & Compliant Built on InterSystems IRIS for Health with HIPAA, SOC 2 certification, ensuring secure global deployments.